Here you go: https://www.bioprocessonline.com/d
Post# of 148165
https://www.bioprocessonline.com/doc/the-peri...uster-0001
"Currently, CytoDyn is producing 2,000 liters per run, with immediate capacity to produce 12,000 liters per run. Upon approvals of leronlimab for its various indications, Pourhassan plans to leverage Samsung Biologics’ 180,000 liter-per-run capacity and Lonza’s 150,000 liter capacity to facilitate the product’s commercial scale-up. And while it’s currently filled to vials, he says the company is already planning the switch to prefilled syringes of leronlimab to meet commercial demand. “The transition to prefilled syringes is strategic for both patient centricity and supply chain efficiency,” explains Pourhassan. “The patient will simply remove the syringe from its box, self-inject, and dispose of the syringe per the instructions on the box. This will eliminate the waste of a significant amount of material.”
I'm guessing the part that references CytoDyn producing refers to their local manufacturer.
No idea how to convert 1liter to mg or if that entire liter is active ingredient, etc. Nor what the dose is for C19 but to say I thought NP stated it only required 2 treatments IIRC.
But that's where I got it from.